FDA, Industries Reach Tentative Pact on User-Fee Act
Biotech: More Funds Needed to Improve Drug Approval Process
BY MARION WEBB
Senior Staff Writer
The biotechnology and pharmaceutical industries and the Food and Drug Administration announced recommendations on renewing a user-fee law that would allow the agency to collect more money and improve the approval process of drugs...